Cargando…
Editorial: Glucocorticoid and bone: Friend or foe
Autores principales: | Baschant, Ulrike, Hauser, Barbara, Winter, Elizabeth Martha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405661/ https://www.ncbi.nlm.nih.gov/pubmed/36034450 http://dx.doi.org/10.3389/fendo.2022.995124 |
Ejemplares similares
-
Endogenous Glucocorticoid Metabolism in Bone: Friend or Foe
por: Martin, Claire S., et al.
Publicado: (2021) -
When to Start and Stop Bone-Protecting Medication for Preventing Glucocorticoid-Induced Osteoporosis
por: Hayes, Kaleen N., et al.
Publicado: (2021) -
Corrigendum: When to Start and Stop Bone-Protecting Medication for Preventing Glucocorticoid-Induced Osteoporosis
por: Hayes, Kaleen N., et al.
Publicado: (2022) -
Bad to the Bone: The Effects of Therapeutic Glucocorticoids on Osteoblasts and Osteocytes
por: Gado, Manuel, et al.
Publicado: (2022) -
The Role of NRF2 in Bone Metabolism – Friend or Foe?
por: Han, Jie, et al.
Publicado: (2022)